EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Accumulated Expenses (2011 - 2026)

EyePoint (EYPT) posted Accumulated Expenses of $6.7 million for Q1 2026, down 72.6% sequentially from $24.4 million in Q4 2025, and down 63.24% YoY from $18.2 million in Q1 2025.

Analysis

EyePoint (EYPT) Accumulated Expenses (2011 - 2026) Analysis & Trends

EyePoint has reported Accumulated Expenses for 16 years, with the latest figure at $6.7 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 63.24% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 63.24% YoY) and the FY2025 annual result came in at $24.4 million, up 34.75% from the prior year.
  • Accumulated Expenses eased to $6.7 million in Q1 2026 per EYPT's latest filing, from $24.4 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $24.4 million in Q4 2025 and troughed at $3.1 million in Q1 2022.
  • A 5-year average of $12.3 million and a median of $13.3 million in 2024 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2026: Accumulated Expenses soared 274.71% in 2024, then tumbled 63.24% in 2026.
  • Over 5 years, Accumulated Expenses stood at $16.4 million in 2022, then retreated by 22.79% to $12.6 million in 2023, then jumped by 43.32% to $18.1 million in 2024, then soared by 34.75% to $24.4 million in 2025, then sank by 72.6% to $6.7 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $6.7 million, $24.4 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.00 Mn
Mar 31, 2026 16.44 Mn
Dec 31, 2025 24.39 Mn
Sep 30, 2025 17.94 Mn
Jun 30, 2025 11.48 Mn
Mar 31, 2025 18.18 Mn
Dec 31, 2024 18.10 Mn
Sep 30, 2024 14.17 Mn
Jun 30, 2024 13.34 Mn
Mar 31, 2024 15.94 Mn
Dec 31, 2023 17.52 Mn
Sep 30, 2023 13.42 Mn
Jun 30, 2023 15.15 Mn
Mar 31, 2023 10.49 Mn
Dec 31, 2022 16.36 Mn
Sep 30, 2022 16.00 Mn
Jun 30, 2022 14.31 Mn
Mar 31, 2022 12.33 Mn
Dec 31, 2021 14.42 Mn
Sep 30, 2021 11.46 Mn